Gliclazide
Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is a second-generation sulfonylurea. It is used in the management of Type 2 diabetes to control blood sugar levels. By stimulating the release of insulin from the pancreas, it reduces blood glucose levels, which helps to prevent the long-term complications of diabetes mellitus.
Mechanism of Action[edit | edit source]
Gliclazide works by increasing the amount of insulin released by the pancreas. This increase in insulin helps to lower blood glucose levels. Gliclazide specifically binds to an ATP-dependent K+ channel on the pancreatic beta cells. This leads to cell membrane depolarization, opening voltage-dependent calcium channels. The influx of calcium ions stimulates the exocytosis of insulin-containing granules, leading to an increase in insulin secretion.
Indications[edit | edit source]
Gliclazide is primarily indicated for the control of blood glucose in patients with Type 2 diabetes when diet, exercise, and weight reduction alone have not been able to control blood glucose levels. It may be used alone or in combination with other antidiabetic medications.
Dosage and Administration[edit | edit source]
The dosage of gliclazide varies depending on the patient's needs, age, and kidney function. It is typically taken once or twice daily, with meals to reduce the risk of gastrointestinal side effects. The initial dose is often low to minimize the risk of hypoglycemia, with a gradual increase based on the patient's response.
Side Effects[edit | edit source]
Common side effects of gliclazide include hypoglycemia, gastrointestinal disturbances such as nausea and indigestion, and skin reactions like rash and itching. Severe hypoglycemia can be a life-threatening condition and requires immediate medical attention.
Contraindications[edit | edit source]
Gliclazide is contraindicated in patients with Type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, and in patients with known hypersensitivity to sulfonylureas. It should be used with caution in elderly patients and those with adrenal or pituitary insufficiency.
Interactions[edit | edit source]
Gliclazide may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), certain antifungals, and alcohol, which can increase the risk of hypoglycemia. It is important for patients to inform their healthcare provider of all medications they are taking to avoid potential interactions.
Pharmacokinetics[edit | edit source]
Gliclazide is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. It is extensively metabolized in the liver and excreted in the urine and feces. The half-life of gliclazide allows for once or twice daily dosing.
Conclusion[edit | edit source]
Gliclazide is an effective medication for the management of Type 2 diabetes, particularly when lifestyle modifications alone have failed to control blood glucose levels. Its mechanism of action, through the stimulation of insulin release, helps to lower blood glucose and manage diabetes-related symptoms. However, like all medications, it must be used carefully to minimize side effects and interactions with other medications.
Diabetes | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP1 injections from $125
W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.
Why choose W8MD?
- Comprehensive care with FDA-approved weight loss medications including:
- loss injections in NYC both generic and brand names:
- weight loss medications including Phentermine, Qsymia, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
- Budget GLP1 weight loss injections in NYC starting from $125.00 biweekly with insurance!
Book Your Appointment
Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen